Donald Trump is set to sign a sweeping spending package that cuts safety-net programs while boosting funding for immigration enforcement. Critics warn of devastating impacts on healthcare and low-income families.
In a nail-biting vote, the Republican-controlled House advanced Trump's megabill, despite internal defections. With a final vote looming, tensions run high over welfare cuts and benefits for the wealthy.
Billionaire investor Bill Ackman raises alarms over left-wing candidate Mamdani's policies, fearing an exodus of wealthy New Yorkers could cripple the city's public services and tax base ahead of the November election.
Wall Street is in turmoil over Zohran Mamdani's victory in the NYC mayoral primary. Investors fear tax hikes and stricter regulations, leading to potential exodus from the city. High-profile financiers express alarm at the implications for New York's economy.
Family offices are facing unprecedented hiring challenges, with 80% struggling to recruit key staff. Discover the reasons behind this staffing crisis and what it means for the ultra-wealthy in today's volatile market.
The One Big Beautiful Bill Act proposed by Trump promises tax cuts but reveals a stark divide between high earners and low-income households. Discover the winners and losers in this controversial legislation!
The emerging GOP tax proposal could add over $2.5 trillion to the federal deficit, igniting fierce debate among lawmakers. Critics warn it risks an economic calamity by favoring tax cuts for the wealthy while slashing essential programs.
After intense internal debates, Republicans reveal their reconciliation bill, promising tax cuts for the wealthy while slashing vital social services. Will the working class pay the price for Trump's agenda?
In a party-line vote, the House Ways and Means Committee has passed a sweeping tax plan that includes significant cuts and new taxes targeting the wealthy, sparking fierce debate among lawmakers. Will it survive the Senate?
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
